Compare SYK & SHEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SYK | SHEL |
|---|---|---|
| Founded | 1941 | 1907 |
| Country | United States | United Kingdom |
| Employees | N/A | 96000 |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.2B | 235.4B |
| IPO Year | 1994 | N/A |
| Metric | SYK | SHEL |
|---|---|---|
| Price | $382.58 | $82.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | ★ $431.08 | $80.90 |
| AVG Volume (30 Days) | 1.8M | ★ 6.0M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 0.92% | ★ 3.51% |
| EPS Growth | ★ 8.25 | N/A |
| EPS | ★ 8.40 | N/A |
| Revenue | ★ $25,116,000,000.00 | N/A |
| Revenue This Year | $9.86 | $2.70 |
| Revenue Next Year | $8.39 | $6.11 |
| P/E Ratio | $45.73 | ★ $26.62 |
| Revenue Growth | ★ 11.16 | N/A |
| 52 Week Low | $329.16 | $58.55 |
| 52 Week High | $404.87 | $84.55 |
| Indicator | SYK | SHEL |
|---|---|---|
| Relative Strength Index (RSI) | 62.20 | 61.13 |
| Support Level | $369.45 | $71.04 |
| Resistance Level | $394.69 | N/A |
| Average True Range (ATR) | 8.00 | 1.24 |
| MACD | 0.92 | 0.20 |
| Stochastic Oscillator | 79.19 | 76.09 |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2024, it produced 1.5 million barrels of liquids and 7.7 billion cubic feet of natural gas per day. At year-end 2024, reserves stood at 9.6 billion barrels of oil equivalent, 48% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with a capacity of 1.6 mmb/d located in the Americas, Asia, and Europe, and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.